MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.18
-0.06
-0.88%
Opening 12:51 11/14 EST
OPEN
6.31
PREV CLOSE
6.23
HIGH
6.33
LOW
6.08
VOLUME
152.17K
TURNOVER
--
52 WEEK HIGH
9.43
52 WEEK LOW
5.13
MARKET CAP
13.18M
P/E (TTM)
-4.2469
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RDHL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RDHL News

  • RedHill And Talicia In H. Pylori Eradication: Just Warming Up
  • Seeking Alpha - Article.17h ago
  • RedHill Biopharma's FDA Approval Moves It Into Large Market Opportunity
  • Seeking Alpha - Article.1d ago
  • RedHill Biopharma to Host Third Quarter 2019 Financial Results Conference Call on November 19, 2019
  • GlobeNewswire.1d ago
  • RedHill Biopharma Announces Publication of RHB-102 Gastroenteritis Phase 3 Study Results in JAMA
  • GlobeNewswire.2d ago

More

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
-0.54%

Hot Stocks

Name
Price
%Change

About RDHL

Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It offers the following gastrointestinal products in the United States: Donnatal, a prescription oral adjunctive drug used in the treatment of Irritable Bowel Syndrome (IBS) and acute enterocolitis, as well as EnteraGam, a medical food intended for the dietary management, under medical supervision, of chronic diarrhea and loose stools. Its clinical-stage pipeline includes: TALICIA (RHB-105), an oral combination therapy for the treatment of Helicobacter pylori infection; RHB-104, an oral combination therapy for the treatment of Crohn's disease; BEKINDA (RHB-102), a once-daily oral pill formulation of ondansetron; RHB-106; YELIVA (ABC294640); MESUPRON, and RIZAPORT (RHB-103).
More

Webull offers RedHill Biopharma Ltd (RDHL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.